Longevity Pulse
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
TutorialsClinical TutorialsVideosContinuous Listen
Free Subscription
Sign In
Deep Dive Audio
Plasma Proteins Predict Epilepsy Years Before DiagnosisLongevity & Aging

Plasma Proteins Predict Epilepsy Years Before Diagnosis

Researchers analyzed 2,920 plasma proteins in 52,372 UK Biobank participants over nearly 14 years, identifying 103 proteins significantly associated with incident epilepsy. Neurofilament light polypeptide (NEFL) and growth differentiation factor 15 (GDF15) showed the strongest associations, with hazard ratios of 2.13 and 1.82 respectively. Pathway analyses revealed a central role for immune response mechanisms. Protein levels showed abnormal trajectory changes up to 15 years before epilepsy diagnosis, and a machine learning model using top-ranked proteins demonstrated meaningful predictive ability for future epilepsy risk. These findings point toward potential blood-based biomarkers and drug targets for earlier epilepsy detection and intervention.

0:00--:--
Read Full Article
Longevity Pulse

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Pulse. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Pulse is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.